People · Operator
Named in public records as an officer, director or promoter · active 2010–2020 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nanotech Energy, Inc. | — | Biotechnology | Series B | $31.6M | $1.1B | 2018 |
| Arrogene, Inc | — | Biotechnology | Seed | $7.2M | $23.3M | 2018 |
| Quantason, LLC | — | Other Health Care | Seed | $1.4M | $34.2M | 2010 |
Robert Snukal at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Snukal on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| JACK KAVANAUGH | 2 | 6 |
| MAURIZIO VECCHIONE | 1 | 3 |
| JEFFREY SPERBER | 1 | 2 |
| ROBERT STUCKELMAN | 1 | 2 |
| JULIA LJUBIMOVA | 1 | 2 |
| Larry A. Couture | 1 | 1 |
| Edward Ray | 1 | 1 |
| Edmond Rambod, Ph.D. | 1 | 1 |
| RANDOLPHE SWENSON | 1 | 1 |
| Richard Kaner | 1 | 1 |
| Mahi DeSilva | 1 | 1 |
| James A. Hosch | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.